StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Business UpdateJun 23, 2026, 06:26 AM

Argenx to Host Autoimmune Myositis R&D Webinar Today

AI Summary

Argenx, a global immunology company, announced it will host an R&D webinar today, June 23, 2026, at 2:00 PM ET. The webinar, titled "R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis," will feature argenx management and scientific leadership alongside external key opinion leaders. A live webcast and supporting presentation slides will be available on the company's investor relations website.

Key Highlights

  • Argenx will host an R&D webinar titled "R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis" on June 23, 2026.
  • The webinar is scheduled for 2:00 PM ET (7:00 AM CET).
  • Argenx management and scientific leadership will be joined by external key opinion leaders.
  • Featured KOLs include Avery LaChance, MD, MPH, FAAD; Arjun Seth, MD; and Rohit Aggarwal, MD, MS.
  • A live webcast will be accessible on the Investors section of the argenx website.
  • Additional presentation slides will be available on argenx’s Events & Presentations website at 2:00 PM ET.